Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

In this Discussion

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

Emerging Markets Small Cap

Looking for a solid EM small cap holding. Any thoughts would be greatly appreciated.


  • FEDDX is truly a mid-cap fund.
    FSCOX is not EM, but is international small-caps.

    MEGMX is EM, but not small-caps. And it's brand new. $44M AUM.
    It's all-cap, "company-first." Macro stuff is not a big priority.

    Sorry, I looked at several. I own PRIDX, but it's been closed. Keep tabs on it. It's a gooder "smid" cap fund. Mostly Middle-cap.
  • edited January 2021
  • There are WAESX and DRESX also.
  • rabockma1 said:


    Hard to find two better than these.
  • Note: Despite its name, WAEMX currently has very little SC exposure per M*.
  • rabockma1 said:


    I suppose the great results make up for the utterly and outrageously high ER on those two.

  • edited January 2021
    High expense ratios pose a sizable hurdle to overcome in the fund's performance. Also VAESX carries a 5% front load. The institutional share is no-load but it requires $100k at Fidelity.

    May want to consider international small cap funds which often have 10-20% EM small exposure. Matthews Asia Small Companies come to mind. Grandeur Peaks and Wasatch are good companies to research, but pay attention to the ERs.
  • I own Grandeur Peaks - GPEOX. $3b mkt cap
    I'm considering also Matthews Emerging Asia - MEASX, $1b mkt cap
  • I was comparing these 3 just last night. Two of them were already mentioned by others above

    GPEOX (I had it in the past, but then later sold it. Still hold their GPGOX)
    WAEMX - Remember it as a high-flier during its early days

    There are not many you find in that space. If you are open for ETFs, then you may have more options.
  • Fidelity shows VAESX as ntf with $2500 minimum.
  • edited January 2021
    I noticed MEASX several years ago.
    The fund performed exceedingly well within its category the first three full calendar years.

    3 Yr return: 10.9% (top 2% of category);
    standard deviation of 8.91%

    MEASX seems to be in a slump since 2017.

    3 Yr return: -13.8% (bottom percentile); 5 Yr return: -4.0% (bottom percentile);
    standard deviation of 21.40%

    Note: Morningstar moved MEASX from the 'Pacific/Asia ex-Japan Stock' category
    to the 'Miscellaneous Region' category sometime after May 31, 2020.

  • Agreed VAESX and WAEMX have high ER's. VAESX at 1.85 and WAEMX art 1.95 but their performance has been good. I prefer VAESX of the 2, M*5 vs M*4 for WAEMX.
  • edited January 2021
    Both available no-load via Schwab
  • While not small cap, I encourage you to take a look at FSEAX which is exclusively focused on Asia and has top 10% returns for the past 1, 3, 5, and 10 year time frames for both Asia Ex-Japan and also emerging markets overall. It is the most consistent fund with strong returns that I have found in EM over the long term. Also held up well in the March downturn. Available at Schwab
  • edited January 2021
    Mutual Fund Ranked by Market Cap

    DFA Emerging Markets Small Cap / 954
    Morgan Stanley Inst EMkts Sm C / 1,021
    Ashmore Emerging Markets Sm Cp / 1,294
    Victory Sophus Emerging Market / 1,376
    RBC Emerging Markets Small Cap / 1,385
    Silk Invest New Horizons Front / 1,527
    AMG TimesSquare Emerging Mkts / 1,586
    Virtus KAR Emerging Markets Sm / 1,738
    Victory Trivalent Emerging Mkt / 1,774
    Templeton Emerging Markets Sma / 1,827

    ETFs such as EWX in this case may be better for pure emerging market small exposure, although I think purity is overrated.
  • How do you decide on the percent allocation to each fund from this thread and others on the site? Thank you
  • From the

    "There is pretty much no time period where EEM has outperformed SPY over the past decade when yields have surged. Add to this that EEM is full of tech (sensitive to rates) and we ask ourselves how people can be so bullish the relative EEM long here..."

    Full Disclosure: I have no idea what will happen this year, nor could I pick out a map of many of the countries where these funds invest in, I'm thinking many others couldn't either...and I also likely wouldn't want any of my money going into some of these countries either, I don't even buy cat food where ingredients are sourced from some of these countries. No, no thanks, not for me.

    Good Luck to all,

  • FSEAX compared to the others mentioned: VAESX, WAEMX, GPEOX - looks very promising. MEASX ... too much of a slump... I may have to look further into FSEAX. Up 5.50 ytd BTW.
  • FSEAX looks amazing. Yes. Helluva 2020. As if all the shit happening around the world wasn't even going on.
  • Not a pure play, but BCSVX has outperformed all except the Fidelity offering.
  • @AZRph and I are on the same page with respect to BCSVX. BTW, welcome. MFO appears to have several new contributors lately, for which I’m grateful.
  • edited January 2021
    BCSVX is an interesting share. One I will add to my watch list. This is probably too much of a generalization but... Emerging Markets is a riskier area. Now add Small Cap to it... a bit more risky. So, when I look at 10 plus years of returns on these funds it seems like none of them beat the S&P 500 and they all have a high Ulcer and low Martin and many have high ER. So, why do I own some FPADX? I will compare to FSEAX and BCSVX and perhaps transfer to one of those or out of EM completely myself. I guess I'm repeating what Baseball Fan said above.
  • FWIW, bought a starter position in FSEAX today to pair with ARTYX for our primary EM exposure.
  • I also have ARTYX and bought a position in MDDCX. Good history and good managers.
  • @jimlenz Just curious. ARTYX is a great fund with what seems like lower risk. I'm wondering what gets you to add MDDCX vs. adding more to ARTYX? Lower turnover? First one's manager tenure is longer but MDDCX is up in the short YTD ... so I'm just curious if you would mind sharing.
  • @JonGaltill: BCSVX is not an EM fund, but it is a small-mid cap international fund that follows the Brown Capital process for selecting stocks of companies that "will make a difference." The domestic version, BCSIX, and BCSVX are heavily weighted in technology and healthcare. I own both of these, as well as the aforementioned ARTYX, an EM fund that holds some US companies.
  • edited January 2021
    @JonGaltlll: As much as I like ARTYX, I have 10% of my IRA already in there. Figured I would try a pure EM fund. MDDCX has good short term results after change in managers a couple years ago. ARTYX is incredible and hope it keeps going.
  • edited February 2021
    Just want to say thank you to the board here. I didn't know the first thing about ARTYX until I found MFO. I had a modest position in FPADX and it was moving along just "fine". After reading a ton of articles / stories about EM and Small Caps for 2021, I knew I needed to pay a little more attention. Researched ARTYX and FSEAX and bought both. Truth be told, in the past, I would have dismissed ARTYX due to ER and life of fund - prefer longer track records.

    I am in both ARTYX and FSEAX and could not be happier. ARTYX is up 17.30% and FSEAX is up 16.63% YTD. So thanks to the posters here for sharing.
  • BCSVX, yes: since PRIDX is closed. I owned Brown's BIAWX Large Growth, domestic. Very pleased. Good profit there, too.
Sign In or Register to comment.